Patent ID: 7723287

Claim:
A method of treating damaged eye epithelium or cornea or of the anterior segment of the eye, comprising: administering or applying to a subject afflicted with a disorder or condition associated with eye epithelium, cornea or anterior segment damage, such damage comprising a corneal epithelial defect, corneal damage following radial keratectomy, membrane rupture, corneal damage associated with eye surgery, eye injury associated with aging, physical, chemical, radiation or medication damage, or chronic corneal edema, a therapeutic amount of an agent comprising one or more members selected from the group consisting of: a high-density lipoprotein; a reconstituted high-density lipoprotein; and a combination of non-cholesterol lipid components capable of reconstituting a high-density lipoprotein comprising one or more of a sphingolipid and a phospholipid, and one or more of a glyceride and a triglyceride.